| Patent(s) and the Corresponding Patented Drug(s) |
Top |
| World Intellectual Property Organization (WIPO) |
| Patent ID |
WO2014177593 |
| Title |
Amorfrutin Analogs As Ppargamma-Modulators. |
| Abstract |
The present invention relates to Amorfrutin analogues and stereoisomeric forms, solvates, hydrates, conjugates and/or pharmaceutically acceptable salts of these compounds as well as pharmaceutical compositions containing at least one of these Amorfrutin analogues together with pharmaceutically acceptable carrier, excipient and/or diluents. Said Amorfrutin analogues have been identified as modulators of the peroxisome proliferator-activated receptors (PPARs), especially PPAR and are useful for the prevention and treatment of metabolic diseases, inflammatory diseases, cancer and preparation of phytomedicals and/or functional food products for prevention of metabolic diseases. |
| Applicant(s) |
Boyce Thompson Institute for Plant Research Inc |
| United States Patent and Trademark Office (USPTO) |
| Patent ID |
US20100022603 |
| Title |
Bicyclic Aryl-Sulfonic Acid [1,3,4]-Thiadiazol-2-Yl-Amides, Processes for Their Preparation, Pharmaceutical Compositions and Methods for Their Use. |
| Applicant(s) |
Sanofi-Aventis |
| Representative Drug(s) |
D0V0JN |
Drug Info
|
N.A. |
[2] |
